This is the case of the homozygous patients with ALAD deficiency, lead poisoning and hereditary tyrosinemia deficiency where the hepatic ALAD activity is less than 1% of the reported normal activity [29], [30]. This evidence concerns the gene ALAD and hepatic porphyria.